Phase 2 CAPTIVATE results of ibrutinib (ibr) plus venetoclax (ven) in first-line chronic lymphocytic leukemia (CLL)

William Wierda, Tanya Siddiqi, Ian W. Flinn, Xavier C. Badoux, Thomas J. Kipps, John N. Allan, Alessandra Tedeschi, John M. Pagel, Bryone J Kuss, Eva González Barca, Paolo Ghia, Karl Eckert, Cathy Zhou, Joi Ninomoto, James P. Dean, Danelle F. James, Constantine Tam